In a regulatory filing, Alphatec Holdings director Paul Segal disclosed the sale of 71,329 common shares of the company on June 12 at a price of $15.15 per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ATEC:
- Fly Insider: Kinnate Biopharma, Arrowhead among week’s notable insider trades
- ATEC Upcoming Earnings Report: What to Expect?
- Alphatec announces $60M offering of common stock
- Alphatec sees Q1 revenue $108.0M-$109.5M, consensus $101.6M
- Needham med tech analysts to hold an analyst/industry conference call